CIBC World Markets »

Vaneck Vectors Pharmaceutical etf shares owned by CIBC World Markets

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by CIBC World Markets from 13F filings

Historical chart of CIBC World Markets investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by CIBC World Markets consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by CIBC World Markets

Quarter filed Position value Share count Share price at filing
2024-03-31 $255k 2.8k 90.55
2022-12-31 $205k 2.6k 77.65
2022-06-30 $247k 3.2k 76.90

More positions owned by CIBC World Markets

Rbc Cad (RY)
Toronto Dominion Bk Ont Com New (TD)
Bk Nova Cad (BNS)
Bank Of Montreal Cadcom (BMO)
Shopify Cl A (SHOP)
Tc Energy Corp (TRP)
Canadian Natural Resources (CNQ)
Suncor Energy (SU)
Enbridge (ENB)
NVIDIA Corporation (NVDA)
Cibc Cad (CM)
Select Sector Spdr Tr Financial (XLF)
Microsoft Corporation (MSFT)
Manulife Finl Corp (MFC)
Canadian Natl Ry (CNI)

View all positions for CIBC World Markets

Top funds holding Vaneck Vectors Pharmaceutical etf

Goldman Sachs Group
Bank of America Corporation
Healthcare Of Ontario Pension Plan Trust Fund
Avalon Trust
Northwestern Mutual Wealth Management Company
Miller Investment Management
Prime Capital Investment Advisors
Jpmorgan Chase & Co
Morgan Stanley
LPL Financial
Phoenix Holdings
Avestar Capital
J.Safra Asset Management
Susquehanna International
Citadel Advisors

View all funds holding Vaneck Vectors Pharmaceutical etf